Cargando…
Differential Induction of the ADAM17 Regulators iRhom1 and 2 in Endothelial Cells
Background: Endothelial function significantly depends on the proteolytic release of surface expressed signal molecules, their receptors and adhesion molecules via the metalloproteinase ADAM17. The pseudoproteases iRhom1 and 2 independently function as adapter proteins for ADAM17 and are essential f...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7736406/ https://www.ncbi.nlm.nih.gov/pubmed/33335915 http://dx.doi.org/10.3389/fcvm.2020.610344 |
_version_ | 1783622785224933376 |
---|---|
author | Babendreyer, Aaron Rojas-González, Diana M. Giese, Anja Adelina Fellendorf, Sandra Düsterhöft, Stefan Mela, Petra Ludwig, Andreas |
author_facet | Babendreyer, Aaron Rojas-González, Diana M. Giese, Anja Adelina Fellendorf, Sandra Düsterhöft, Stefan Mela, Petra Ludwig, Andreas |
author_sort | Babendreyer, Aaron |
collection | PubMed |
description | Background: Endothelial function significantly depends on the proteolytic release of surface expressed signal molecules, their receptors and adhesion molecules via the metalloproteinase ADAM17. The pseudoproteases iRhom1 and 2 independently function as adapter proteins for ADAM17 and are essential for the maturation, trafficking, and activity regulation of ADAM17. Bioinformatic data confirmed that immune cells predominantly express iRhom2 while endothelial cells preferentially express iRhom1. Objective: Here, we investigate possible reasons for higher iRhom1 expression and potential inflammatory regulation of iRhom2 in endothelial cells and analyze the consequences for ADAM17 maturation and function. Methods: Primary endothelial cells were cultured in absence and presence of flow with and without inflammatory cytokines (TNFα and INFγ). Regulation of iRhoms was studied by qPCR, involved signaling pathways were studied with transcriptional inhibitors and consequences were analyzed by assessment of ADAM17 maturation, surface expression and cleavage of the ADAM17 substrate junctional adhesion molecule JAM-A. Results: Endothelial iRhom1 is profoundly upregulated by physiological shear stress. This is accompanied by a homeostatic phenotype driven by the transcription factor KLF2 which is, however, only partially responsible for regulation of iRhom1. By contrast, iRhom2 is most prominently upregulated by inflammatory cytokines. This correlates with an inflammatory phenotype driven by the transcription factors NFκB and AP-1 of which AP-1 is most relevant for iRhom2 regulation. Finally, shear stress exposure and inflammatory stimulation have independent and no synergistic effects on ADAM17 maturation, surface expression and JAM-A shedding. Conclusion: Conditions of shear stress and inflammation differentially upregulate iRhom1 and 2 in primary endothelial cells which then results in independent regulation of ADAM17. |
format | Online Article Text |
id | pubmed-7736406 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-77364062020-12-16 Differential Induction of the ADAM17 Regulators iRhom1 and 2 in Endothelial Cells Babendreyer, Aaron Rojas-González, Diana M. Giese, Anja Adelina Fellendorf, Sandra Düsterhöft, Stefan Mela, Petra Ludwig, Andreas Front Cardiovasc Med Cardiovascular Medicine Background: Endothelial function significantly depends on the proteolytic release of surface expressed signal molecules, their receptors and adhesion molecules via the metalloproteinase ADAM17. The pseudoproteases iRhom1 and 2 independently function as adapter proteins for ADAM17 and are essential for the maturation, trafficking, and activity regulation of ADAM17. Bioinformatic data confirmed that immune cells predominantly express iRhom2 while endothelial cells preferentially express iRhom1. Objective: Here, we investigate possible reasons for higher iRhom1 expression and potential inflammatory regulation of iRhom2 in endothelial cells and analyze the consequences for ADAM17 maturation and function. Methods: Primary endothelial cells were cultured in absence and presence of flow with and without inflammatory cytokines (TNFα and INFγ). Regulation of iRhoms was studied by qPCR, involved signaling pathways were studied with transcriptional inhibitors and consequences were analyzed by assessment of ADAM17 maturation, surface expression and cleavage of the ADAM17 substrate junctional adhesion molecule JAM-A. Results: Endothelial iRhom1 is profoundly upregulated by physiological shear stress. This is accompanied by a homeostatic phenotype driven by the transcription factor KLF2 which is, however, only partially responsible for regulation of iRhom1. By contrast, iRhom2 is most prominently upregulated by inflammatory cytokines. This correlates with an inflammatory phenotype driven by the transcription factors NFκB and AP-1 of which AP-1 is most relevant for iRhom2 regulation. Finally, shear stress exposure and inflammatory stimulation have independent and no synergistic effects on ADAM17 maturation, surface expression and JAM-A shedding. Conclusion: Conditions of shear stress and inflammation differentially upregulate iRhom1 and 2 in primary endothelial cells which then results in independent regulation of ADAM17. Frontiers Media S.A. 2020-12-01 /pmc/articles/PMC7736406/ /pubmed/33335915 http://dx.doi.org/10.3389/fcvm.2020.610344 Text en Copyright © 2020 Babendreyer, Rojas-González, Giese, Fellendorf, Düsterhöft, Mela and Ludwig. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cardiovascular Medicine Babendreyer, Aaron Rojas-González, Diana M. Giese, Anja Adelina Fellendorf, Sandra Düsterhöft, Stefan Mela, Petra Ludwig, Andreas Differential Induction of the ADAM17 Regulators iRhom1 and 2 in Endothelial Cells |
title | Differential Induction of the ADAM17 Regulators iRhom1 and 2 in Endothelial Cells |
title_full | Differential Induction of the ADAM17 Regulators iRhom1 and 2 in Endothelial Cells |
title_fullStr | Differential Induction of the ADAM17 Regulators iRhom1 and 2 in Endothelial Cells |
title_full_unstemmed | Differential Induction of the ADAM17 Regulators iRhom1 and 2 in Endothelial Cells |
title_short | Differential Induction of the ADAM17 Regulators iRhom1 and 2 in Endothelial Cells |
title_sort | differential induction of the adam17 regulators irhom1 and 2 in endothelial cells |
topic | Cardiovascular Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7736406/ https://www.ncbi.nlm.nih.gov/pubmed/33335915 http://dx.doi.org/10.3389/fcvm.2020.610344 |
work_keys_str_mv | AT babendreyeraaron differentialinductionoftheadam17regulatorsirhom1and2inendothelialcells AT rojasgonzalezdianam differentialinductionoftheadam17regulatorsirhom1and2inendothelialcells AT gieseanjaadelina differentialinductionoftheadam17regulatorsirhom1and2inendothelialcells AT fellendorfsandra differentialinductionoftheadam17regulatorsirhom1and2inendothelialcells AT dusterhoftstefan differentialinductionoftheadam17regulatorsirhom1and2inendothelialcells AT melapetra differentialinductionoftheadam17regulatorsirhom1and2inendothelialcells AT ludwigandreas differentialinductionoftheadam17regulatorsirhom1and2inendothelialcells |